WPRIM Management System> DCMS> Journal of Breast Cancer> 2011> 14> 3

Volume: 14 Issue: 3

1. Clinical Outcome of Magnetic Resonance Imaging-Detected Additional Lesions in Breast Cancer Patients. Page:213—218
2. The Prognostic Significance of the Lymph Node Ratio in Axillary Lymph Node Positive Breast Cancer. Page:204—212
3. The Role of Lymphovascular Invasion as a Prognostic Factor in Patients with Lymph Node-Positive Operable Invasive Breast Cancer. Page:198—203
4. The Impact of Local and Regional Recurrence on Distant Metastasis and Survival in Patients Treated with Breast Conservation Therapy. Page:191—197
5. G-protein Coupled Estrogen Receptor 1 Expression in Primary Breast Cancers and Its Correlation with Clinicopathological Variables. Page:185—190
6. Vascular Endothelial Growth Factor Levels in Relation to Oxidative Damage and Antioxidant Status in Patients with Breast Cancer. Page:181—184
7. Can CD44+/CD24- Tumor Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?. Page:175—180
8. Heat Shock Protein as Molecular Targets for Breast Cancer Therapeutics. Page:167—174
9. Invited Commentary on: Can CD44+/CD24- Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?. Page:251—252
10. Invasive Lobular Breast Cancer Presenting an Unusual Metastatic Pattern in the Form of Peritoneal and Rectal Metastases: A Case Report. Page:247—250
11. Undifferentiated Pleomorphic Sarcoma of the Male Breast Causing Diagnostic Challenges. Page:241—246
12. Borderline Phyllodes Tumor with an Incidental Invasive Tubular Carcinoma and Lobular Carcinoma In Situ Component: A Case Report. Page:237—240
13. Nation-Wide Korean Breast Cancer Data from 2008 Using the Breast Cancer Registration Program. Page:229—236
14. Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer. Page:223—228
15. The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty. Page:219—222